Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 120,887 | 112,198 | 101,663 | 103,020 | 95,921 |
| Cost of Goods | 64,653 | 61,015 | 54,287 | 58,074 | 59,089 |
| Gross Profit | 56,234 | 51,183 | 47,376 | 44,946 | 36,832 |
| Operating Expenses | 32,635 | 26,429 | 37,103 | 34,714 | 34,042 |
| Operating Income | 24,252 | 24,769 | 10,560 | 10,306 | 2,879 |
| Interest Expense | 168 | 527 | 86 | 104 | 88 |
| Other Income | 3,078 | 13,404 | 3,743 | -5,088 | -9,533 |
| Pre-tax Income | 27,162 | 37,646 | 14,217 | 5,114 | -6,742 |
| Income Tax | 7,194 | 6,686 | 5,595 | 1,155 | -950 |
| Net Income Continuous | 19,760 | 30,960 | 8,622 | 3,959 | -5,792 |
| Minority Interests | N/A | 1,412 | 855 | -1,082 | 481 |
| Net Income | $19,760 | $29,548 | $7,767 | $5,041 | $-6,273 |
| EPS Basic Total Ops | 0.41 | 0.62 | 0.16 | 0.11 | -0.14 |
| EPS Basic Continuous Ops | 0.42 | 0.64 | 0.18 | 0.08 | -0.12 |
| EPS Diluted Total Ops | 0.40 | 0.59 | 0.16 | 0.10 | -0.13 |
| EPS Diluted Continuous Ops | 0.40 | 0.62 | 0.17 | 0.08 | -0.12 |
| EBITDA(a) | $30,008 | $30,497 | $16,600 | $16,268 | $8,689 |